858 Therapeutics Competitors and Similar CompaniesClear all

858 Therapeutics's competitors and similar companies include MeMed Diagnostics and CN Bio.

	858 Therapeutics 858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule medications that operate on oncology therapeutic targets, such as proteins that govern RNA and the innate immune response.	MeMed Diagnostics MeMed Diagnostics is a med-tech and bio convergence company that provides diagnostic solutions.	CN Bio CN Bio Innovations (formerly known as Zyoxel) is a company that develops organ-on-a-chip systems for human drug discovery and preclinical research.
Founding Date	Founding Date 2019	Founding Date 2009	Founding Date 2008
Type	Type Private	Type Private	Type Subsidiary
Tags	Tags Technology biotech drug development medtech platform	Tags Technology biotech drug development medical diagnostics medtech platform	Tags Technology bioengineering biotech drug development medtech platform
Locations	Locations San Diego, US HQ	Locations Tirat Carmel, IL HQ	Locations Milton, GB HQ
Employees	Employees 11	Employees 1081% decrease	Employees 576% increase
Funding
Latest funding round	Latest funding round $ 60m (over 4 years ago)	Latest funding round $ 2.8m (over 6 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 80.1m	Total funding raised $ 79.9m	Total funding raised $ 11.5m

For sources of this data, please see the company profile

Tirat Carmel, IL

Employees

108↓ 1% decrease

MeMed Diagnostics is a med-tech and bio convergence company that provides diagnostic solutions.

Milton, GB

CN Bio Innovations (formerly known as Zyoxel) is a company that develops organ-on-a-chip systems for human drug discovery and preclinical research.

Funding